Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World

被引：0
|
作者：
Chen, C. [1 ]
机构：
[1] Zunyi Med Univ, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; Neoadjuvant therapy; PD-1; inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-24
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    [J]. LUNG CANCER, 2023, 183
  • [2] Efficacy and safety evaluation of neoadjuvant immunotherapy plus chemotherapy for resectable non-small cell lung cancer in real world
    Fang, Min
    Hang, Qingqing
    Jiang, Haitao
    Cai, Lei
    Hu, Jinlin
    Ying, Hangjie
    Gu, Qing
    Yu, Xiaofu
    Liu, Jinshi
    Lai, Xiaojing
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [3] Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
    Riano, Ivy
    Abuali, Inas
    Sharma, Aditya
    Durant, Jewelia
    Dragnev, Konstantin H. H.
    [J]. PHARMACEUTICALS, 2023, 16 (02)
  • [4] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    [J]. HELIYON, 2023, 9 (09)
  • [5] Neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Finkelstein, EI
    Urschel, JD
    Takita, H
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (04) : 437 - 439
  • [6] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Y.
    Yan, B.
    You, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S108 - S109
  • [8] Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
    Faltermeier, Claire M.
    Lee, Jay M.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (12) : 4328 - 4335
  • [9] Real-world evidence of advanced non-small cell lung carcinoma treated with an immune checkpoint inhibitor plus chemotherapy
    Xu, Zihan
    Zhang, Huien
    Ma, Guikai
    Meng, Wenjuan
    Du, Junliang
    Wu, Xin
    Yang, Baohong
    Wang, Ningning
    Ding, Yanhong
    Zhang, Qingyun
    Li, Na
    Zhang, Xuede
    Yu, Guohua
    Liu, Shuzhen
    Li, Zhenhua
    [J]. ONCOLOGY LETTERS, 2024, 28 (03)
  • [10] Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogenedriven resectable non-small cell lung cancer (NSCLC)
    Rosner, Samuel
    Sivapalan, Lavanya
    Zahurak, Marianna
    Thummalapalli, Rohit
    Rayes, Roni
    Connor, Sydney
    Sanber, Khaled
    Reuss, Joshua E.
    Pereira, Gavin
    Smith, Kellie Nicole
    Anagnostou, Valsamo
    Broderick, Stephen
    Jones, David Randolph
    Brahmer, Julie R.
    Marrone, Kristen A.
    Spicer, Jonathan
    Chaft, Jamie E.
    Forde, Patrick M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345